If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,014.00    95.00 (4.95%)
Bid:
2,006.00
Ask:
2,010.00
Spread: 4.00 (0.199%)
Market Cap: £3.38b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Johnson Matthey Battery Materials update

12 Jan 2022 14:19

RNS Number : 2549Y
Johnson Matthey PLC
12 January 2022
 

12th January 2022

 

Johnson Matthey Plc

(the Company)

Johnson Matthey provides an update on its intention to exit Battery Materials

 

Johnson Matthey, a global leader in sustainable technologies, today provides an update on its intention to exit Battery Materials.

 

On 11th November 2021, we announced our intention to pursue the sale of all or parts of our Battery Materials business with the ultimate intention of exiting. Further to that announcement, we have held discussions with a number of parties about a sale of the entire business. These discussions have not resulted in an agreement to sell the entire business as a going concern. Consequently, we are announcing today that we are commencing consultation with our employees about our proposed closure of the Battery Materials business, and we are pursuing the sale of its individual assets.

 

In our interim results we fully impaired the carrying value of our battery materials assets as at 30th September 2021, resulting in a charge of £314 million. While the outcome of the sales process is uncertain, full or partial closure will result in additional impairment charges, the settlement of contractual liabilities, redundancy, closure and abandonment costs as we indicated at our interim results on 24th November 2021. After anticipated asset disposal proceeds, we currently estimate these cash costs will be in the order of £150 million, which will be recorded as an exceptional item outside of underlying operating profit in our full year results.

 

 

ENDS

 

Enquiries: 

Investor Relations

Martin Dunwoodie

Louise Curran

Carla Fabiano

 

Director of Investor Relations

Senior Investor Relations Manager

Senior Investor Relations Manager

 

+44 20 7269 8241

+44 20 7269 8235

+44 20 7269 8004

 

Media

Barney Wyld

Harry Cameron

 

 

Group Corporate Affairs Director

Tulchan Communications

 

 

+44 7485 337498

+44 20 7353 4200

 

 

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEALFAFFXAEFA
Date   Source Headline
10th Jan 202212:16 pmRNSHolding(s) in Company
10th Jan 20227:00 amRNSTransaction in Own Shares
7th Jan 202212:06 pmRNSDirector/PDMR Shareholding
7th Jan 20227:00 amRNSTransaction in Own Shares
6th Jan 202211:39 amRNSDirector/PDMR Shareholding
6th Jan 20227:00 amRNSTransaction in Own Shares
5th Jan 20225:21 pmRNSDirector/PDMR Shareholding
5th Jan 20227:00 amRNSTransaction in Own Shares
4th Jan 202211:45 amRNSDirector/PDMR Shareholding
4th Jan 20229:40 amRNSTotal Voting Rights
4th Jan 20227:00 amRNSTransaction in Own Shares
31st Dec 20217:00 amRNSTransaction in Own Shares
30th Dec 20217:00 amRNSTransaction in Own Shares
29th Dec 20217:00 amRNSTransaction in Own Shares
24th Dec 20217:00 amRNSTransaction in Own Shares
23rd Dec 20219:30 amRNSDirector/PDMR Shareholding
23rd Dec 20217:00 amRNSTransaction in Own Shares
22nd Dec 20214:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20217:00 amRNSTransaction in Own Shares - Replacement
21st Dec 20216:28 pmRNSTransaction in Own Shares
21st Dec 20214:15 pmRNSDirector/PDMR Shareholding
21st Dec 20211:47 pmRNSDirector/PDMR Shareholding
21st Dec 20217:00 amRNSShare buyback programme
20th Dec 20214:11 pmRNSDirector/PDMR Shareholding
17th Dec 20214:16 pmRNSHolding(s) in Company
17th Dec 20213:44 pmRNSDirector/PDMR Shareholding
17th Dec 20213:18 pmRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSSale of Health
16th Dec 20212:20 pmRNSHolding(s) in Company
10th Dec 20214:40 pmRNSHolding(s) in Company
26th Nov 20215:15 pmRNSHolding(s) in Company
25th Nov 20214:30 pmRNSHolding(s) in Company
24th Nov 20217:00 amRNSJohnson Matthey half year results 30th Sept 2021
24th Nov 20217:00 amRNSSale of Advanced Glass Technologies
19th Nov 20213:30 pmRNSHolding(s) in Company
19th Nov 20212:02 pmRNSDirector/PDMR Shareholding
17th Nov 20219:47 amRNSHolding(s) in Company
11th Nov 20217:00 amRNSIntent to exit Battery Materials, trading update
11th Nov 20217:00 amRNSChief Executive Announcement
1st Nov 20218:30 amRNSJane Griffiths - External Directorship
22nd Oct 202110:13 amRNSDirector/PDMR Shareholding
12th Oct 202110:47 amRNSHolding(s) in Company
5th Oct 20218:00 amRNSJohn O'Higgins - External Directorship
28th Sep 202112:25 pmRNSHolding(s) in Company
20th Sep 20211:20 pmRNSHolding(s) in Company
16th Sep 202112:45 pmRNSDirector/PDMR Shareholding
25th Aug 20216:01 pmRNSHolding(s) in Company
20th Aug 20212:51 pmRNSDirector/PDMR Shareholding
18th Aug 20214:21 pmRNSDirector/PDMR Shareholding
18th Aug 20214:12 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.